Marker Therapeutics, Inc. MRKR
Super Investor & Insider
1
Fondi che lo detengono
#1530
Rank consenso
1.4%
% dei portafogli
$19,500
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| David Katz · Matrix Asset Advisors | 0% | — | 15,000 | $19,500 |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Marker Therapeutics, Inc. is a biotechnology company focused on the development of innovative therapeutic solutions in the pharmaceuticals and biotech sector. Headquartered in Houston, Texas, and founded in 1999, the company specializes in advancing treatments designed to address significant unmet medical needs. Marker…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees5
TickerMRKR
Statistics
Market Cap$22.7M
Revenue (TTM)$3.5M
Net Income-$12.2M
Net Margin-343.0%
EPS$-0.79
P/E-1.73
P/S6.44
P/B1.66
EV/EBITDA-0.74
ROE-77.0%
Dividend Yield—
Price$1.36
Data: Twelve Data · Revenue = mcap / P/S